Purchase this article with an account.
Stanislao Rizzo, Maria Cristina Savastano, Daria Bortolotti, Alfonso Savastano, Gloria Gambini, Francesca Caccuri, Valentina Gentili, Roberta Rizzo; COVID-19 Ocular Prophylaxis: The Potential Role of Ozonated-Oils in Liposome Eyedrop Gel. Trans. Vis. Sci. Tech. 2021;10(9):7. doi: https://doi.org/10.1167/tvst.10.9.7.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To assess whether ozonated-oil in liposome eyedrop gel (OED) could be used to prevent the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection in an in vitro infection model.
First, we tested the efficacy of OED on in vitro cell regeneration and dry eye resolution in human corneal epithelial cells (hCE-2). Second, we assessed the in vitro anti-SARS-CoV-2 infection efficacy of OED using Vero E6 cells. Tissues were examined to assess different parameters: morphology, histology, and mRNA expression at 24 hours after treatment.
OED could restore 50% of the scratch in the monolayer of hCE-2 cells in vitro compared with the 25% obtained with phosphate-buffered saline solution (PBS). At 24 hours after treatment with OED, the number of microvilli and the mucin network were restored, as observed using scanning electron microscopy. In Vero E6 cells infected with a primary SARS‐CoV-2 strain and treated with OED two times/day, viral replication was found to be inhibited, with a 70‐fold reduction observed at 72 hours after infection compared with that under the untreated and PBS-treated conditions.
SARS-CoV-2 transmission through the ocular surface should not be ignored. Although the prevalence of coronavirus disease 2019 conjunctivitis infection is low, the need for a barrier to prevent possible viral infection is warranted. OED treatment may prevent the risk of SARS-CoV-2 infection after 72 hours of twice-daily applications.
Dry eye condition might be a risk factor for SARS-CoV-2 infection and OED treatment may have a preventive role.
This PDF is available to Subscribers Only